Skip to main content
Vivacelle Bio Phase 3 Trial
The Lancet Journal – Efficacy and Safety of Phospholipid Nanoparticles (VBI-S) in Reversing Intractable Hypotension in Patients with Septic Shock Medical Journal

The Lancet Journal – Efficacy and Safety of Phospholipid Nanoparticles (VBI-S) in Reversing Intractable Hypotension in Patients with Septic Shock

A Multicentre, Open-Label, Repeated Measures, Phase 2a Clinical Pilot Trial Background Since the 1990’s attempts to favorably modulate nitric oxide (NO) have been unsuccessful. We hypothesized that because NO is…
18689pwpadmin
January 4, 2024